Decreased phosphatidylethanolamine binding protein expression correlates with Aβ accumulation in the Tg2576 mouse model of Alzheimer's disease

Neurobiology of Aging

Volumn 27, Issue 4, 2006, Pages 614-623

  George, Amee J ^a,b   Holsinger, R M Damian ^a,b   McLean, Catriona A ^c   Tan, Seong Seng ^a   Scott, Hamish S ^d   Cardamone, Tina ^a,b   Cappai, Roberto ^a,b   Masters, Colin L ^a,b   Li, Qiao Xin ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

A amyloid; Alzheimer's disease; Amyloid precursor protein; Hippocampus; Phosphatidylethanolamine binding protein; Tg2576; Transgenic mouse

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MESSENGER RNA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TISSUE SECTION; TRANSGENIC MOUSE;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENILE PLAQUES;

EID: 33344471456     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.03.014     Document Type: Article

References (52)

1. N.J. Abbott Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology Neurochem Int 45 4 2004 545
2. Y. Araki, M.E. Vierula, T.L. Rankin, D.R. Tulsiani, and M.C. Orgebin-Crist Isolation and characterization of a 25-kilodalton protein from mouse testis: sequence homology with a phospholipid-binding protein Biol Reprod 47 5 1992 832
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM-IV) fourth ed. 1994 American Psychiatric Association Washington DC
4. R.T. Bartus, R.L. Dean 3rd, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 4558 1982 408
5. I. Bernier, and P. Jolles Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain Biochim Biophys Acta 790 2 1984 174
6. K. Beyreuther, T. Dyrks, C. Hilbich, U. Monning, G. Konig, and G. Multhaup Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome Prog Clin Biol Res 379 1992 159
7. D.A. Butterfield, and C.M. Lauderback Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress Free Radic Biol Med 32 11 2002 1050
8. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J Neurochem 85 6 2003 1394
9. G.D. Ciccotosto, D. Tew, C.C. Curtain, D. Smith, D. Carrington, and C.L. Masters Enhanced toxicity and cellular binding of a modified amyloid beta peptide with a methionine to valine substitution J Biol Chem 279 41 2004 42528
10. V. Colangelo, J. Schurr, M.J. Ball, R.P. Pelaez, N.G. Bazan, and W.J. Lukiw Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling J Neurosci Res 70 3 2002 462
11. K.C. Corbit, N. Trakul, E.M. Eves, B. Diaz, M. Marshall, and M.R. Rosner Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein J Biol Chem 278 15 2003 13061
12. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, and G.W. Small Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 5123 1993 921
13. M. Cruts, and C. Van Broeckhoven Molecular genetics of Alzheimer's disease Ann Med 30 6 1998 560
14. G.B. Frisoni, and M. Trabucchi Clinical rationale of genetic testing in dementia J Neurol Neurosurg Psychiatry 62 3 1997 217
15. A.J. George, R.M. Holsinger, C.A. McLean, K.M. Laughton, K. Beyreuther, and G. Evin APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease Neurobiol Dis 16 1 2004 124
16. S.D. Ginsberg, S.E. Hemby, V.M. Lee, J.H. Eberwine, and J.Q. Trojanowski Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons Ann Neurol 48 1 2000 77
17. D.K. Grandy, E. Hanneman, J. Bunzow, M. Shih, C.A. Machida, and J.M. Bidlack Purification, cloning, and tissue distribution of a 23-kDa rat protein isolated by morphine affinity chromatography Mol Endocrinol 4 9 1990 1370
18. Group Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease Neurobiol Aging 18 4 Suppl. 1997 S1
19. J. Hardy Amyloid, the presenilins and Alzheimer's disease Trends Neurosci 20 4 1997 154
20. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett, and D.A. Evans Alzheimer disease in the US population: prevalence estimates using the 2000 census Arch Neurol 60 8 2003 1119
21. U. Hengst, H. Albrecht, D. Hess, and D. Monard The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors J Biol Chem 276 1 2001 535
22. D.M. Hickox, G. Gibbs, J.R. Morrison, K. Sebire, K. Edgar, and H.H. Keah Identification of a novel testis-specific member of the phosphatidylethanolamine binding protein family, pebp-2 Biol Reprod 67 3 2002 917
23. N. Hori, K.S. Chae, K. Murakawa, R. Matoba, A. Fukushima, and K. Okubo A human cDNA sequence homologue of bovine phosphatidylethanolamine-binding protein Gene 140 2 1994 293
24. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, and S. Younkin Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 5284 1996 99
25. N. Ida, T. Hartmann, J. Pantel, J. Schroder, R. Zerfass, and H. Forstl Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay J Biol Chem 271 37 1996 22908
26. H. Johnston, I. Koukoulas, K. Jeyaseelan, A. Armugam, L. Earnest, and R. Baird Ontogeny of aquaporins 1 and 3 in ovine placenta and fetal membranes Placenta 21 1 2000 88
27. Y. Kazuki, M. Kimura, R. Nishigaki, Y. Kai, S. Abe, and C. Okita Human chromosome 21q22.2-qter carries a gene(s) responsible for downregulation of mlc2a and PEBP in Down syndrome model mice Biochem Biophys Res Commun 317 2 2004 491
28. P. Kehoe, F. Wavrant-De Vrieze, R. Crook, W.S. Wu, P. Holmans, and I. Fenton A full genome scan for late onset Alzheimer's disease Hum Mol Genet 8 2 1999 237
29. E. Levy-Lahad, W. Wasco, P. Poorkaj, D.M. Romano, J. Oshima, and W.H. Pettingell Candidate gene for the chromosome 1 familial Alzheimer's disease locus Science 269 5226 1995 973
30. Q.X. Li, C. Maynard, R. Cappai, C.A. McLean, R.A. Cherny, and T. Lynch Intracellular accumulation of detergent-soluble amyloidogenic Abeta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice J Neurochem 72 6 1999 2479
31. Q.X. Li, S. Whyte, J.E. Tanner, G. Evin, K. Beyreuther, and C.L. Masters Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets Lab Invest 78 4 1998 461
32. K. Lorenz, M.J. Lohse, and U. Quitterer Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2 Nature 426 6966 2003 574
33. J.F. Loring, X. Wen, J.M. Lee, J. Seilhamer, and R. Somogyi A gene expression profile of Alzheimer's disease DNA Cell Biol 20 11 2001 683
34. M. Maki, N. Matsukawa, H. Yuasa, Y. Otsuka, T. Yamamoto, and H. Akatsu Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease J Neuropathol Exp Neurol 61 2 2002 176
35. C. Moore, A.C. Perry, S. Love, and L. Hall Sequence analysis and immunolocalisation of phosphatidylethanolamine binding protein (PBP) in human brain tissue Brain Res Mol Brain Res 37 1-2 1996 74
36. R.E. Mrak, and W.S. Griffin Trisomy 21 and the brain J Neuropathol Exp Neurol 63 7 2004 679
37. M. Mullan, F. Crawford, K. Axelman, H. Houlden, L. Lilius, and B. Winblad A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid Nat Genet 1 5 1992 345
38. K. Ojika, S. Mitake, T. Kamiya, N. Kosuge, and M. Taiji Two different molecules, NGF and free-HCNP, stimulate cholinergic activity in septal nuclei in vitro in a different manner Brain Res Dev Brain Res 79 1 1994 1
39. K. Ojika, S. Mitake, N. Tohdoh, S.H. Appel, Y. Otsuka, and E. Katada Hippocampal cholinergic neurostimulating peptides (HCNP) Prog Neurobiol 60 1 2000 37
40. G.M. Pasinetti Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia J Neurosci Res 65 6 2001 471
41. M.A. Pericak-Vance, M.P. Bass, L.H. Yamaoka, P.C. Gaskell, W.K. Scott, and H.A. Terwedow Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12 JAMA 278 15 1997 1237
42. A.C. Perry, L. Hall, A.E. Bell, and R. Jones Sequence analysis of a mammalian phospholipid-binding protein from testis and epididymis and its distribution between spermatozoa and extracellular secretions Biochem J 301 Pt 1 1994 235
43. M.R. Prasad, M.A. Lovell, M. Yatin, H. Dhillon, and W.R. Markesbery Regional membrane phospholipid alterations in Alzheimer's disease Neurochem Res 23 1 1998 81
44. P.H. Reddy, S. McWeeney, B.S. Park, M. Manczak, R.V. Gutala, and D. Partovi Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease Hum Mol Genet 13 12 2004 1225
45. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, and S.H. Joo Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 8 1993 1467
46. F. Schoentgen, and P. Jolles From structure to function: possible biological roles of a new widespread protein family binding hydrophobic ligands and displaying a nucleotide binding site FEBS Lett 369 1 1995 22
47. N. Seddiqi, F. Bollengier, P.M. Alliel, J.P. Perin, F. Bonnet, and S. Bucquoy Amino acid sequence of the Homo sapiens brain 21-23 kDa protein (neuropolypeptide h3), comparison with its counterparts from Rattus norvegicus and Bos taurus species, and expression of its mRNA in different tissues J Mol Evol 39 6 1994 655
48. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, and M. Ikeda Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 6534 1995 754
49. P.C. Simister, M.J. Banfield, and R.L. Brady The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family Acta Crystallogr D Biol Crystallogr 58 Pt 6 Pt 2 2002 1077
50. W.J. Strittmatter, K.H. Weisgraber, D.Y. Huang, L.M. Dong, G.S. Salvesen, and M. Pericak-Vance Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease Proc Natl Acad Sci USA 90 17 1993 8098
51. A.H. Tammer, G. Coia, R. Cappai, S. Fuller, C.L. Masters, and P. Hudson Generation of a recombinant Fab antibody reactive with the Alzheimer's disease-related Abeta peptide Clin Exp Immunol 129 3 2002 453
52. R.E. Tanzi, and L. Bertram New frontiers in Alzheimer's disease genetics Neuron 32 2 2001 181